Observational studyStroke and vascular neurology2020

Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.

Yi Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.